Recurrence of atrial fibrillation after switching from brand to generic atenolol

Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pharmacol Pharmacother
Hlavní autoři: Gallelli, Luca, Maida, Francesca, Staltari, Orietta, Rende, Pierandrea, Russo, Emilio, Caroleo, Benedetto, De Sarro, Giovambattista
Médium: Artigo
Jazyk:Inglês
Vydáno: Medknow Publications & Media Pvt Ltd 2015
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4319249/
https://ncbi.nlm.nih.gov/pubmed/25709353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.149146
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky